Top Medical News

Night-Time Only Apomorphine Infusion Shows Benefit to Treating Parkinson Disease Insomnia

September 30, 2022

By Marco Meglio

Sleep changes experienced by patients on apomorphine infusion were indicated by scores on Insomnia Severity Index and Clinical Global Impression-Improvement Scale.

NeurologyLive® Friday 5 — September 30, 2022

September 30, 2022

By NeurologyLive® Staff

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 23, 2022.

Electroacupuncture for Insomnia Significantly Improves Quality of Sleep in Patients With Depression

September 30, 2022

By Isabella Ciccone, MPH

In a randomized clinical trial, the application of electroacupuncture treatment for insomnia in patients with depression significantly improved the quality of sleep in comparison with sham acupuncture or the control group.

Sleep Breathing Disorders Appear Common for Patients with Duchenne Muscular Dystrophy

September 30, 2022

By Isabella Ciccone, MPH

A questionnaire-based study from Saudi Arabia on sleep quality revealed that sleep-related disorders, such as obstructive sleep apnea, are relatively common in patients with Duchenne muscular dystrophy.

Open-Label Extension Data Highlight Tofersen’s Ability to Reduce SOD1 Protein in ALS

September 29, 2022

By Marco Meglio

Despite not improving clinical end points, treatment with tofersen was associated with reduced in the total concentration of SOD1 protein and neurofilament light chain, a marker of axonal injury.

Featured

Mind Moments Podcast

Click here to listen to Mind Moments™, a podcast from NeurologyLive® that brings you exclusive interviews with expert neurologists and clinicians.

NeuroVoices

Click here to read NeurologyLive®'s NeuroVoices series of in-depth, exclusive conversations with a variety of experts in the care and management of patients with neurologic diseases about topics in clinical care and therapeutic development.

Gold Standard Centers

Click here to check out the latest deep dive into examples of institutional success in medicine with our Gold Standard Centers feature series.

Brain Games

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics.

EEGTalk

EEGTalk is a series dedicated to teaching EEG reading skills in neurology in a way that is both digestible and fun, hosted by Fábio A. Nascimento, MD, and Brandon Westover MD, PhD. Click here to watch.

MEDICAL WORLD NEWS

Click here to see what's streaming on Medical World News.

Latest Videos

Peers & Perspectives: The Induction vs Escalation Approach to MS and the TREAT-MS Trial

Novel Oral Treatment Selection in RRMS

Comparing Reactive Microglia and Astrocytes in Secondary Progressive Multiple Sclerosis

Understanding Safety, Amyloid-Related Imaging Abnormalities With Lecanemab: Sharon Cohen, MD, FRCPC

Multifaceted Use of NuroSleeve to Restore Arm Function in Neurological Diseases: Joe Kardine, MS, OTR, CBIS

Assessing Lecanemab’s Effect in Early Alzheimer Disease: Sharon Cohen, MD, FRCPC

Overcoming Difficulties in the Care Paradigm for Insomnia: Ashgan Elshinawy, DO

New Treatments for Duchenne Muscular Dystrophy: Emma Ciafaloni, MD

Evaluating the Treatment Evolution of Myasthenia Gravis and Use of Immunosuppressants: Nicholas Silvestri, MD, FAAN

Unique Composition of CNM-Au8 to Treat MS and ALS: Michael Hotchkin

Rituximab as Initial gMG Treatment, WVE-003 Proves Positive in HD, and Incidence of Guillian-Barré After COVID-19 Vaccination

CNM-Au8’s Impact on Survival, Energetic Dysfunction in ALS: Michael Hotchkin

Changing the Treatment of Diabetic and Inflammatory Neuropathies: Brian Callaghan, MD, MS

Most Recent

Alzheimer Disease Agent Lecanemab Shows Reduction in CDR-Sum of Boxes in Clarity AD

September 28, 2022

Article

The investigational treatment from Eisai and Biogen significantly reduced the Clinical Dementia Rating-Sum of Boxes scores among patients with early AD, with safety and ARIA-E and ARIA-H incidence as expected.

Acupuncture Proves Effective as Method to Improve Sleep Quality for Post-Stroke Insomnia

September 27, 2022

Article

In a randomized controlled trial, results demonstrated that acupuncture is to be efficacious in improving insomnia, quality of life, and affective symptoms for patients with ischemic stroke.

Unraveling the Roots of ALS Through Reactivation of HERVs and Antibody Levels

September 27, 2022

Article

Avindra Nath, MD, clinical director of the National Institute of Neurological Disorders and Stroke, provided insight on new findings that may explain the symptoms of certain cases of sporadic ALS.

Virtual Reality Training May Improve Quality of Care in Lower Limb Spasticity With OnabotulinumtoxinA

September 27, 2022

Article

Results from pilot program using a VR-based platform suggest medical trainees may benefit from further VR training to gain a complete baseline knowledge of treating lower limb spasticity with onabotulinumtoxinA.

Long-Term Safety of MS Treatment Ofatumumab Confirmed in ALITHIOS Extension

September 27, 2022

Article

Over a 3.5-year treatment period, the risk of serious infections or malignancies, few of which were previously reported, did not increase with additional ofatumumab exposure.

Tele-Yoga Breathing for Respiratory Function Proves Feasibility in Amyotrophic Lateral Sclerosis

September 26, 2022

Article

A nonrandomized pilot study demonstrated high adherence rates and acceptability ratings with tele-yoga breathing in patients with ALS, proving that it is a safe and feasible practice.

Dimethyl Fumarate Shows Low MS Relapse Rates, Encouraging Safety After 13-Year Analysis

September 26, 2022

Article

Over a long-term follow-up, a high proportion of patients were compliant to therapy, with adverse events mild-to-moderate in nature, regardless of individuals being on continuous treatment or switched from placebo.

Vaccinated Individuals With Myasthenia Gravis With COVID-19 Infection are More at Health Risk

September 26, 2022

Article

Adults with myasthenia gravis who contracted COVID-19 were at twice the risk of hospitalization, ICU admission, and death based on data from a recent population-based study.

The Future of Multiple Sclerosis Treatment

September 26, 2022

Video

Ahmed Obeidat, MD, PhD; Benjamin Greenberg, MD; and Hesham Abboud, MD, share their hopes about the evolution of future mutiple sclerosis care and express their gratitude for the next generation of neurologists.

Novel Mechanisms of Action for Multiple Sclerosis Treatment

September 26, 2022

Video

Drs Hesham Abboud and Benjamin Greenberg share their excitement for the future of multiple scelrosis treatment and comment on emerging therapies and novel mechanisms of action.

Latest SAP Content

Night-Time Only Apomorphine Infusion Shows Benefit to Treating Parkinson Disease Insomnia

NeurologyLive® Friday 5 — September 30, 2022

Electroacupuncture for Insomnia Significantly Improves Quality of Sleep in Patients With Depression

Understanding Safety, Amyloid-Related Imaging Abnormalities With Lecanemab: Sharon Cohen, MD, FRCPC

View More SAP Content